Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink

BACKGROUND: Intensification of metformin monotherapy with additional glucose-lowering drugs is often required in patients with type 2 diabetes (T2D). This study evaluated changes in HbA1c and weight, as well as treatment persistence, associated with different second-line therapies used in UK clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilding, John, Godec, Thomas, Khunti, Kamlesh, Pocock, Stuart, Fox, Robin, Smeeth, Liam, Clauson, Per, Fenici, Peter, Hammar, Niklas, Medina, Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047134/
https://www.ncbi.nlm.nih.gov/pubmed/30008267
http://dx.doi.org/10.1186/s12916-018-1085-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047134/
https://www.ncbi.nlm.nih.gov/pubmed/30008267
http://dx.doi.org/10.1186/s12916-018-1085-8

Ejemplares similares